Jiangxi Sanxin Medtec Co.,Ltd. (300453.SZ)
CNY 7.91
(1.15%)
CNY 7.91
(1.15%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 336.13 Million CNY | 3.41% |
| 2022 | 300.99 Million CNY | 13.64% |
| 2021 | 259.23 Million CNY | 26.71% |
| 2020 | 206.67 Million CNY | 73.8% |
| 2019 | 118.97 Million CNY | 45.66% |
| 2018 | 79.11 Million CNY | 18.3% |
| 2017 | 70.05 Million CNY | 11.7% |
| 2016 | 57.95 Million CNY | -19.29% |
| 2015 | 75.61 Million CNY | 3.5% |
| 2014 | 72.95 Million CNY | -0.22% |
| 2013 | 71.36 Million CNY | 7.24% |
| 2012 | 67.44 Million CNY | 41.63% |
| 2011 | 48.85 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 76.09 Million CNY | -11.74% |
| 2024 Q2 | 80.24 Million CNY | 1.21% |
| 2024 Q1 | 65.04 Million CNY | -15.69% |
| 2023 Q1 | 57.44 Million CNY | 25.91% |
| 2023 Q2 | 56.83 Million CNY | -1.05% |
| 2023 FY | - CNY | 3.41% |
| 2023 Q4 | 86.53 Million CNY | 34.63% |
| 2023 Q3 | 64.27 Million CNY | 13.08% |
| 2022 FY | - CNY | 13.64% |
| 2022 Q4 | 45.62 Million CNY | -6.58% |
| 2022 Q3 | 48.83 Million CNY | -32.93% |
| 2022 Q2 | 72.81 Million CNY | 19.23% |
| 2022 Q1 | 61.07 Million CNY | 26.73% |
| 2021 Q2 | 47.8 Million CNY | 3.28% |
| 2021 Q3 | 58.04 Million CNY | 21.41% |
| 2021 FY | - CNY | 26.71% |
| 2021 Q1 | 46.28 Million CNY | 2.03% |
| 2021 Q4 | 48.19 Million CNY | -16.97% |
| 2020 Q3 | 46.23 Million CNY | 6.1% |
| 2020 Q2 | 43.58 Million CNY | 126.57% |
| 2020 Q1 | 19.23 Million CNY | -31.8% |
| 2020 FY | - CNY | 73.8% |
| 2020 Q4 | 45.36 Million CNY | -1.89% |
| 2019 Q1 | 7.12 Million CNY | -54.88% |
| 2019 FY | - CNY | 45.66% |
| 2019 Q4 | 28.2 Million CNY | -13.11% |
| 2019 Q3 | 32.46 Million CNY | 121.98% |
| 2019 Q2 | 14.62 Million CNY | 105.1% |
| 2018 Q4 | 15.79 Million CNY | 7.94% |
| 2018 FY | - CNY | 18.3% |
| 2018 Q3 | 14.63 Million CNY | 29.86% |
| 2018 Q2 | 11.27 Million CNY | 11.32% |
| 2018 Q1 | 10.12 Million CNY | -6.98% |
| 2017 Q1 | 8.99 Million CNY | -19.66% |
| 2017 FY | - CNY | 11.7% |
| 2017 Q4 | 10.88 Million CNY | -24.38% |
| 2017 Q3 | 14.39 Million CNY | 6.86% |
| 2017 Q2 | 13.47 Million CNY | 49.78% |
| 2016 Q1 | 10.93 Million CNY | -47.12% |
| 2016 Q4 | 11.19 Million CNY | -13.34% |
| 2016 FY | - CNY | -19.29% |
| 2016 Q2 | 12.13 Million CNY | 11.0% |
| 2016 Q3 | 12.91 Million CNY | 6.41% |
| 2015 FY | - CNY | 3.5% |
| 2015 Q1 | 78.61 Million CNY | 333.25% |
| 2015 Q4 | 20.68 Million CNY | 81.51% |
| 2015 Q3 | 11.39 Million CNY | 123.06% |
| 2015 Q2 | -49.4 Million CNY | -162.84% |
| 2014 Q1 | 77.6 Million CNY | 0.0% |
| 2014 FY | - CNY | -0.22% |
| 2014 Q2 | -50.02 Million CNY | -164.46% |
| 2014 Q3 | 14.92 Million CNY | 129.83% |
| 2014 Q4 | 18.14 Million CNY | 21.59% |
| 2013 FY | - CNY | 7.24% |
| 2012 FY | - CNY | 41.63% |
| 2011 FY | - CNY | 0.0% |